Lamivudine diastereoselective synthesis method
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 湖南千金湘江药业股份有限公司
- Publication Date
- 2009-09-30
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to a production method of nucleoside analogs, in particular to a diastereoselective synthesis production method of lamivudine. Background technique:
[0002] Lamivudine (lamivudine, Zeffix, chemical name: 2,3-dideoxy-3-thiocytosine, referred to as 3TC) is a nucleoside analog and a viral DNA reverse transcriptase inhibitor. For chronic hepatitis B, the treatment of patients with proven decompensated liver disease or histologically confirmed active and (or) fibrosis. Its chemical structure is:
[0003]
[0004] Lamivudine, a novel deoxynucleoside analog, is (2R-cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl )-2(1H)-Pyrimidinone is one of the four optical isomers of the cis left-handed optical enantiomer, which is a new generation of nucleoside antiviral drugs superior to the anti-HIV drug AZT. It has obvious effects on human immunodeficiency virus HIV and has been approved by dozens of countries to treat AIDS. Since 199...